EC 35 Pill - yellow capsule/oblong
Pill with imprint EC 35 is Yellow, Capsule/Oblong and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Actavis.
Risedronate is used in the treatment of Osteoporosis; Prevention of Osteoporosis; Paget's Disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for EC 35
Risedronate Sodium Delayed-Release
- Imprint
- EC 35
- Strength
- 35 mg
- Color
- Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis
- Inactive Ingredients
-
edetate disodium,
ferric oxide yellow,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polysorbate 80,
microcrystalline cellulose,
silicon dioxide,
sodium starch glycolate type A potato,
stearic acid,
magnesium silicate,
triethyl citrate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00430-0979 | Warner Chilcott |
| 00591-3876 (Discontinued) | Watson Pharmaceuticals, Inc. |
Related images for "EC 35"
More about risedronate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (79)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: bisphosphonates
- Breastfeeding
- En español
Patient resources
- Risedronate drug information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.